Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Business
  • Tech
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Research

Laser Photonics Launches R&D Initiative to Drive Innovation

  • The Pharma Data
  • November 30, 2024

Laser Photonics Corporation a global leader in the development of industrial laser systems for material processing applications, has announced the launch of a new research and development (R&D) initiative aimed…

Read MoreLaser Photonics Launches R&D Initiative to Drive Innovation
  • BusinessPress Releases

Devonian Reports 2024 Annual Financial Results

  • The Pharma Data
  • November 30, 2024

Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical-stage botanical pharmaceutical company specializing in the development of unique botanical pharmaceutical and cosmeceutical products, has announced its financial…

Read MoreDevonian Reports 2024 Annual Financial Results
  • Business

Generic Injectables Market Report 2024-2030: Patent Expirations and New Opportunities

  • The Pharma Data
  • November 30, 2024

The global Generic Injectables market, valued at $95.2 billion in 2023, is on a strong growth trajectory and is projected to reach $206.8 billion by 2030, growing at a CAGR…

Read MoreGeneric Injectables Market Report 2024-2030: Patent Expirations and New Opportunities
  • News

Bayer Expands Global Incubator Network with Co.Lab Berlin, Welcomes MyoPax as First Resident

  • The Pharma Data
  • November 30, 2024

Bayer has inaugurated Bayer Co.Lab Berlin, a state-of-the-art life science incubator located at the company’s Pharmaceuticals Division Global Headquarters Campus. Positioned near leading research and clinical institutions in Berlin, the…

Read MoreBayer Expands Global Incubator Network with Co.Lab Berlin, Welcomes MyoPax as First Resident
  • Business

UCB Advances New Launches and Divests Mature Product Business in China

  • The Pharma Data
  • November 30, 2024

UCB, a global biopharmaceutical leader, has announced the successful completion of its sale, divestment, and licensing agreement for its mature neurology and allergy portfolio in China. The transaction, valued at…

Read MoreUCB Advances New Launches and Divests Mature Product Business in China
  • News

EU Approves BeiGene’s TEVIMBRA for Advanced Esophageal and Gastric Cancer Treatment

  • The Pharma Data
  • November 30, 2024

BeiGene has announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with chemotherapy as a first-line treatment for two aggressive cancer types: esophageal squamous cell carcinoma (ESCC) and…

Read MoreEU Approves BeiGene’s TEVIMBRA for Advanced Esophageal and Gastric Cancer Treatment
  • Press Releases

New Report Urges Continued Investment in Infection Prevention Programs

  • The Pharma Data
  • November 30, 2024

Nearly five years after the onset of COVID-19, a new report from the World Health Organization (WHO) reveals limited progress in closing critical gaps in infection prevention and control (IPC)…

Read MoreNew Report Urges Continued Investment in Infection Prevention Programs
  • News

Dr. Reddy’s Launches Toripalimab in India, First Immuno-Oncology Drug for Nasopharyngeal Carcinoma

  • The Pharma Data
  • November 29, 2024

Dr. Reddy’s Laboratories Ltd has announced the launch of Toripalimab in India, marking a significant advancement in the treatment of nasopharyngeal carcinoma (NPC). Toripalimab, a New Biological Entity (NBE), is…

Read MoreDr. Reddy’s Launches Toripalimab in India, First Immuno-Oncology Drug for Nasopharyngeal Carcinoma
  • Business

Global Head and Neck Cancer Therapeutics Market: 2024 Overview and 2030 Forecast

  • The Pharma Data
  • November 29, 2024

The global market for head and neck cancer therapeutics is estimated to reach $1.7 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of…

Read MoreGlobal Head and Neck Cancer Therapeutics Market: 2024 Overview and 2030 Forecast
  • Research

Altasciences Partners with Metsera to Advance Early-Stage Clinical Trials for Obesity Treatment

  • The Pharma Data
  • November 29, 2024

Altasciences, a full-service early-phase contract research organization, is proud to have partnered with Metsera, Inc., a clinical-stage biopharmaceutical company dedicated to advancing next-generation therapies for obesity and metabolic diseases. This…

Read MoreAltasciences Partners with Metsera to Advance Early-Stage Clinical Trials for Obesity Treatment
  • News

New Guidance for Sustainable, Climate-Resilient Healthcare Facilities

  • The Pharma Data
  • November 29, 2024

The World Health Organization (WHO) has published a new report titled Safe, Climate-Resilient, and Environmentally Sustainable Healthcare Facilities: An Overview. This guide offers policymakers, health administrators, facility managers, and healthcare…

Read MoreNew Guidance for Sustainable, Climate-Resilient Healthcare Facilities
  • Press Releases

Second IHR Emergency Meeting on Mpox Surge 2024

  • The Pharma Data
  • November 29, 2024

The Director-General of the World Health Organization (WHO) has released the report from the second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the mpox outbreak of…

Read MoreSecond IHR Emergency Meeting on Mpox Surge 2024
PrevNext
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • HistoSonics Secures New Financing Round Backed by Yosemite and Other Strategic Investors
  • Arrowhead Wins EU Approval for REDEMPLO in Familial Chylomicronemia Syndrome
  • Trace Neuroscience Launches Global Clinical Program for ALS Therapy TRCN-1023
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.